One of the West Swedish companies included in the artificial intelligence (AI) survey is Medfield Diagnostics. The company has developed stroke diagnostic tools to effectively distinguish blood clots from bleeding. Stroke has been on the agenda recently with international stroke day on May 8. Stefan Blomsterberg, CEO, shares some insights into the company’s work with artificial intelligence.
“For us, it is important to be able to own and collect data effectively, in a way that doesn’t infringe on an individual’s privacy.”
“To be able to continuously develop and improve our product, we must have the freedom to use the data we collect, preferably without needing to set up clinical studies.”
“We also spend a lot of time structuring and annotating data. Automating and controlling the collection of clinical data would be very useful.”
Of the challenges highlighted in the report, Stefan Blomsterberg ranks the 3 most important:
- Ownership of data – patient or company
- Regulatory (dynamic or traditional development approach)
- Structure and annotate data.
If you want to read more about the AI survey, you can download a presentation here.
Early diagnosis, where you can quickly distinguish a blood clot from bleeding, is everything in terms of continued quality of life after a stroke. Assessments in the ambulance or at the hospital can be speeded up using Medfield’s technology, with the aim to be able to give the right treatment at the right time.